<DOC>
	<DOCNO>NCT01207895</DOCNO>
	<brief_summary>The purpose study determine positron emission tomography ( PET ) image image agent call 18F-fluorodeoxythymidine ( [ 18F ] -FLT ) allow investigator measure well tumor ( ) respond treatment without take tissue sample ( biopsy ) . Additionally , investigator want determine possible predict well tumor ( ) might respond treatment [ 18F ] -FLT PET imaging .</brief_summary>
	<brief_title>Molecular Determinants Affecting Fluoro-L-thymidine ( FLT ) Positron Emission Tomography ( PET ) Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<criteria>Subjects know rectal cancer . Subjects must sign approve consent form . Subjects must 18 year age old . Children le 18 exclude . Pregnant woman woman breast feed exclude study . A serum beta HCG also perform premenopausal female subject . Patients acutely ill deem treat physician suitable candidate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>